Quantification of vascular disease burden to stratify dementia for diagnosis and care management

Award Number
Collaborative R&D
Status / Stage
1 April 2015 -
30 June 2017
Duration (calculated)
02 years 02 months
Innovate UK (UKRI)
Funding Amount
Funder/Grant study page
Innovate UK UKRI
Contracted Centre
Ixico Technologies Limited
Contracted Centre Webpage

WHO Catergories
Development of Biomarkers
Disease Type
Dementia (Unspecified)

CPEC Review Info
Reference ID389
ResearcherReside Team


Award Number1405_CDR2_HEALT_ND1
Status / StageCompleted
Start Date20150401
End Date20170630
Duration (calculated) 02 years 02 months
Funder/Grant study pageInnovate UK UKRI
Contracted CentreIxico Technologies Limited
Contracted Centre Webpage
Funding Amount£332,530.00


Most of the 700,000 people in the UK with dementia have not received a formal diagnosis, so are denied access to benefitial treatments. The current NHS approach is slow (often more than 12 months) and often of low quality. This project will further develop a novel digital healthcare system, allowing dementia diagnoses to be made quickly, cost effectively, and earlier in the disease course. The focus of this work is on the combination of general imaging biomarkers for dementia with biomarkers specifically developed to assess a patients vascular burden to dementia. The advanced decision support tool will provide input on a differential diagnosis between the two most prevalent types of dementia, Alzheimer’s disease and vascular dementia.